Stock Events

Stock Events

Syros Pharmaceuticals (0LC7.LSE) Q1 2025 Earnings

6MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.85

-0.6

-0.35

-0.1

Details

Expected EPS

-0.6497

Actual EPS

-0.6497

Surprise EPS

0

Surprise Percent

+0%

Description

Syros Pharmaceuticals (0LC7.LSE) has reported earnings of -0.6497 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.